Determining the specificity and biological functions of widespread host mRNA degradation by RNase L
确定 RNase L 广泛降解宿主 mRNA 的特异性和生物学功能
基本信息
- 批准号:9757551
- 负责人:
- 金额:$ 6.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-09 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsAntiviral resistanceApoptosisApoptoticAutoimmune DiseasesBioinformaticsBiologicalBiological ProcessCellsChronicConsensusDiseaseDouble-Stranded RNAElementsEndoribonucleasesFluorescent in Situ HybridizationGene ExpressionGenesGenetic TranscriptionGenetic TranslationGrantHigh-Throughput Nucleotide SequencingHigh-Throughput RNA SequencingInfectionInflammationInflammatoryInnate Immune ResponseInnate Immune SystemInterferon-betaInterferonsLeadMalignant NeoplasmsMammalian CellMediatingMessenger RNAModelingMolecularMultiple SclerosisMutagenesisNull LymphocytesPathway interactionsPatternPhosphorylationProductionProteinsResearchResistanceRheumatoid ArthritisRibonucleasesRibosomal RNARibosomesRoleSpecificityStressStructureSystemic Lupus ErythematosusTestingTranslatingTranslationsWorkbasechronic infectioncytokineexperimental studyhuman diseasehuman pathogenimmune system functioninnovationinsightmRNA DecaymRNA ExpressionmRNA Transcript Degradationnew technologynovelpathogenpromoterpseudotoxoplasmosis syndromeresponseribosome profilingsingle cell analysissingle molecule
项目摘要
Project Summary/Abstract
The innate immune response is crucial for controlling infection by human pathogens. However, over-activation
of the innate immune response can cause chronic inflammation that leads to human diseases, such as cancers
and autoimmune disorders. To better understand and treat these diseases, developing a deeper understanding
of how the innate immune system functions is paramount. In particular, the mechanisms that lead to global host
shut-off of translation in response to double-stranded RNA (dsRNA), while allowing the expression of dsRNA-
induced antiviral and pro-inflammatory mRNAs has remained an incompletely understood aspect of the innate
immune response.
Assessment of the potent antiviral endoribonuclease, ribonuclease L (RNase L), at the single-cell level revealed
that it is the primary driver of translational arrest and functions by promoting rapid and widespread turnover of
mRNAs. This is a significant shift in the understanding of dsRNA-induced translational arrest, as it would permit
translation of mRNAs that are not degraded by RNase L. Consistent with this, the mRNA of the potent antiviral
interferon-b (IFN-b) cytokine escapes RNase L-mediated mRNA turnover, potentially allowing for translation of
the IFN-b mRNA.
Based on these preliminary findings, this application proposes to test the hypothesis that widespread RNase L-
mediated mRNA turnover functions to preferentially promote translation of antiviral mRNAs that are resistant to
RNase L-mediated mRNA turnover. These findings may provide novel insights into RNase L-mediated
translational arrest and antiviral gene expression that will have translational importance for understanding and
treating human disease associated with dysregulation of the innate immune response. Aim 1: High-throughput
sequencing and single-molecule fluorescent in situ hybridization (smFISH) will be used to identify mRNAs in
addition to the IFN-b mRNA that are resistant to RNase L-mediated mRNA turnover. Aim 2: Targeted
mutagenesis, chimeric mRNAs, and heterologous promoters, will be used to determine the mechanistic basis by
which RNase L resistant mRNA escape RNase L-mediated mRNA turnover. Aim 3: Single-cell analysis of mRNA
expression and protein translation in conjunction with ribosomal profiling will be performed to determine if RNase
L-mediated mRNA promotes the translation of RNase L resistant mRNAs. Completion of these aims will
determine the breadth of mRNAs resistant to RNase L-driven mRNA turnover, determine the mechanism(s) by
which mRNAs escape RNase L-mediated mRNA turnover, and provide a novel mechanism by which RNase L
regulates antiviral gene expression during the innate immune response.
!
项目摘要/摘要
先天免疫反应对于控制人类病原体感染至关重要。但是,过度激活
先天免疫反应会导致慢性炎症,导致人类疾病,例如癌症
和自身免疫性疾病。更好地理解和治疗这些疾病,建立更深入的理解
先天免疫系统功能的最重要。特别是导致全球主机的机制
响应双链RNA(dsRNA)的翻译关闭,同时允许dsRNA-的表达
诱导的抗病毒和促炎性mRNA仍然是一个不完全理解的先天性的
免疫反应。
在单细胞水平上评估有效的抗病毒核酸酶核糖核酸酶L(RNase L)
通过促进快速而广泛的营业额,它是转化逮捕和功能的主要驱动力
mrnas。这是对DSRNA诱导的翻译逮捕的理解的重大转变,因为这将允许
RNase L.不降解的mRNA的翻译。
干扰素B(IFN-B)细胞因子逃脱RNase L介导的mRNA转换,有可能允许翻译
IFN-B mRNA。
基于这些初步发现,该应用提出了测试广泛的RNase l-的假设
介导的mRNA转离功能优先促进抗病毒mRNA的翻译
RNase L介导的mRNA更新。这些发现可能为RNase L介导的新颖见解提供了新的见解
翻译停滞和抗病毒基因表达将对理解和
治疗与先天免疫反应失调相关的人类疾病。目标1:高通量
测序和单分子荧光原位杂交(Smfish)将用于识别MRNA
除了对RNase L介导的mRNA更新具有抗性的IFN-B mRNA。目标2:针对性
诱变,嵌合mRNA和异源启动子将用于确定机械基础
这是RNase L耐药mRNA逃脱RNase L介导的mRNA转换。目标3:mRNA的单细胞分析
将进行表达和蛋白质翻译与核糖体分析结合的表达和蛋白质翻译,以确定RNase是否是否
L介导的mRNA促进了RNase L耐药mRNA的翻译。这些目标的完成将
确定抗RNase L驱动mRNA的mRNA宽度,确定机制
mRNA逃脱了RNase L介导的mRNA转换,并提供了一种新型机制
在先天免疫反应期间调节抗病毒基因表达。
呢
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James M Burke其他文献
James M Burke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James M Burke', 18)}}的其他基金
Understanding the OAS/RNase L pathway during pathogenic viral infections
了解病原性病毒感染期间的 OAS/RNase L 途径
- 批准号:
10714902 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别:
Determining the specificity and biological functions of widespread host mRNA degradation by RNase L
确定 RNase L 广泛降解宿主 mRNA 的特异性和生物学功能
- 批准号:
10116269 - 财政年份:2019
- 资助金额:
$ 6.16万 - 项目类别:
相似国自然基金
核苷类抗病毒药物嵌合型核酸纳米载体的构筑及其抗病毒性能研究
- 批准号:52303174
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向病毒核衣壳蛋白质相分离的抗病毒药物发现及机制研究
- 批准号:82302491
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水环境中抗病毒药物及其转化副产物的识别及生态毒性效应研究
- 批准号:52300245
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
猴痘病毒入侵融合复合物、DNA聚合酶复合物的结构解析以及抗病毒药物的开发
- 批准号:82241081
- 批准年份:2022
- 资助金额:65.00 万元
- 项目类别:专项项目
CCHFV的致病机理及抗病毒药物研究
- 批准号:U22A20336
- 批准年份:2022
- 资助金额:255.00 万元
- 项目类别:联合基金项目
相似海外基金
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
- 批准号:
10678459 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别:
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
- 批准号:
10750627 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别:
Unlocking microglia targeting for neurotherapeutics
解锁神经治疗药物的小胶质细胞靶向
- 批准号:
10696509 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别:
Characterization of JT-4-173, a Potent Antiviral that Inhibits HIV-1 by a Novel Mechanism of Action
JT-4-173 的表征,一种通过新颖作用机制抑制 HIV-1 的强效抗病毒药物
- 批准号:
10762518 - 财政年份:2023
- 资助金额:
$ 6.16万 - 项目类别: